This course reviews the definitions, incidence, prevalence, risk factors, co-morbidities, and clinical signs and symptoms of dry eye and ocular surface disease. New and emerging therapeutic interventions for these conditions are then presented, including recently approved pharmaceuticals, interventional procedures, and medical devices, as well as pipeline therapies in various stages of development.

Dr. Chris Wroten will be joining Dr. April Jasper for the CE Session. Dr. Carl Spear will be joining Dr. Jasper and Wroten for the Non-CE session immediately following, where they will have an interactive discussion and answer any questions that could not be answered during the CE Session.

Thank you to our partner in education, MacuHealth.

Chris Wroten OD

Appearances